-
Founded in:
2003-09-26 -
Country:
China -
Address:
No. 1, Yunan Street, Kaifeng City -
Tax NO.:
914102007551588773 -
Registered Funds:
204.568562 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Anisodamine |
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, improve microcirculation, relax gastrointestinal smooth muscle, and inhibit its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting saliva secretion and dilating pupils is weaker, which is 1/20-1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.
More
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasms caused by acetylcholine, can also relieve microvascular spasms, improve microcirculation, relax gastrointestinal smooth muscle, and inhibit its peristalsis. Its effect is slightly weaker than atropine, and its effect of inhibiting digestive gland secretion is 1/10 of atropine. Its effect of inhibiting saliva secretion and dilating pupils is weaker, which is 1/20-1/10 of atropine. Because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine. |
17659-49-3 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Anisodamine |
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasm caused by acetylcholine, relieve microvascular spasm, improve microcirculation, relax gastrointestinal smooth muscle and inhibit its peristalsis; its effect of inhibiting digestive gland secretion is 1/10 of that of atropine; its effect of inhibiting saliva secretion and dilating the pupil is weaker, which is 1/20-1/10 of that of atropine; because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than that of atropine.
More
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasm caused by acetylcholine, relieve microvascular spasm, improve microcirculation, relax gastrointestinal smooth muscle and inhibit its peristalsis; its effect of inhibiting digestive gland secretion is 1/10 of that of atropine; its effect of inhibiting saliva secretion and dilating the pupil is weaker, which is 1/20-1/10 of that of atropine; because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than that of atropine. |
17659-49-3 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfamethoxazole |
It is a sulfonamide antibiotic. When used in combination with trimethoprim, it can double block bacterial folate metabolism and enhance the synergistic antibacterial effect, especially the antibacterial effect on Escherichia coli, Haemophilus influenzae, and Staphylococcus aureus is significantly enhanced compared with a single drug.
More
It is a sulfonamide antibiotic. When used in combination with trimethoprim, it can double block bacterial folate metabolism and enhance the synergistic antibacterial effect, especially the antibacterial effect on Escherichia coli, Haemophilus influenzae, and Staphylococcus aureus is significantly enhanced compared with a single drug. |
100mg | 723-46-6 | 33 |
| Trimethoprim |
It is a sulfonamide antibiotic. When used in combination with sulfamethoxazole, it can double block bacterial folate metabolism, enhance synergistic antibacterial effects, and reduce drug-resistant strains.
More
It is a sulfonamide antibiotic. When used in combination with sulfamethoxazole, it can double block bacterial folate metabolism, enhance synergistic antibacterial effects, and reduce drug-resistant strains. |
20mg | 738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fenbufen |
This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.
More
This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin. |
36330-85-5 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fenbufen |
This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.
More
This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin. |
36330-85-5 | 9 |